Cullinan Therapeutics, Inc. (CGEM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 79K | 0 | 0 | 0 | 0 | 0 | 0 | 77K | 76K | 77K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -79K | 0 | 0 | 0 | 0 | 0 | 0 | -77K | -76K | -77K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | 100% | - | - | - | - | - | - |
| Operating Expenses | 53.7M | 55.26M | 55.59M | 75.8M | 55M | 55.05M | 48.85M | 49.95M | 42.91M | 45.41M | 45.24M | 37.6M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.57M | 12.31M | 13.63M | 14.77M | 13.54M | 14.56M | 13.35M | 13.69M | 12.27M | 10.56M | 10.98M | 10.21M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 42.12M | 42.95M | 41.97M | 61.03M | 41.46M | 40.49M | 35.51M | 36.26M | 30.65M | 34.85M | 33.82M | 27.39M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 440K | 0 |
| Operating Income | -53.7M | -55.26M | -55.59M | -75.8M | -55M | -55.05M | -48.85M | -50.03M | -42.99M | -45.48M | -45.24M | -37.6M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 2.36% | -0.38% | -13.8% | -51.51% | -27.93% | -21.02% | -7.98% | -33.03% | 31.5% | -39.49% | -52% | -115.69% |
| EBITDA | -53.62M | -55.18M | -55.52M | -75.72M | -54.92M | -54.97M | -48.78M | -49.95M | -42.91M | -45.41M | -45.16M | -37.52M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 2.37% | -0.38% | -13.81% | -51.59% | -27.98% | -21.06% | -8.01% | -33.11% | 31.54% | -39.51% | -51.77% | -115.66% |
| D&A (Non-Cash Add-back) | 79K | 79K | 79K | 77K | 76K | 77K | 76K | 77K | 76K | 77K | 80K | 81K |
| EBIT | -53.7M | -55.26M | -50.61M | -75.8M | -55M | -55.05M | -48.85M | -50.03M | -42.99M | -45.48M | -44.8M | -37.6M |
| Net Interest Income | 4.1M | 4.62M | 5.09M | 5.92M | 6.58M | 7.51M | 8.38M | 8.07M | 5.69M | 5.92M | 5.88M | 5.32M |
| Interest Income | 4.1M | 4.62M | 5.09M | 5.92M | 6.58M | 7.51M | 8.38M | 8.07M | 5.69M | 5.92M | 5.88M | 5.32M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.04M | 4.55M | 4.99M | 5.74M | 6.5M | 7.52M | 8.29M | 8M | 5.65M | 5.8M | 6.06M | 5.39M |
| Pretax Income | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.53M | -40.56M | -42.03M | -37.34M | -39.69M | -39.18M | -32.21M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 117K | 0 | 0 | 0 | -14.12M | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -0.25% | 0% | 0% | 0% | 35.59% | 0% | 0% |
| Net Income | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.65M | -40.56M | -42.03M | -37.15M | -23.8M | -39.18M | -32.21M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -2.39% | -6.43% | -24.78% | -66.69% | -30.56% | -100.17% | -3.51% | -30.46% | 35.91% | 11.12% | -57.97% | -118.42% |
| Net Income (Continuing) | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.65M | -40.56M | -42.03M | -37.34M | -25.56M | -39.18M | -32.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192K | 0 | 0 |
| EPS (Diluted) | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 |
| EPS Growth % | -2.44% | -6.17% | -22.86% | -56.58% | 4.65% | -44.64% | 23.91% | 6.17% | 39.44% | 5.08% | -70.37% | -121.49% |
| EPS (Basic) | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 |
| Diluted Shares Outstanding | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M |
| Basic Shares Outstanding | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |